Dr. Murray M. Lumpkin was formerly the deputy commissioner for international programs at the Food and Drug Administration (FDA). Dr. Lumpkin was responsible for all of FDA's international activities, including:
- interactions with foreign counterpart agencies and major multinational public health organizations
- foreign confidentiality and other agreements
- foreign technical cooperation and harmonization programs
- interactions with embassies in Washington, D.C.
- activities of FDA’s Office of International Programs, including the 13 FDA foreign posts in China, Europe, India, Latin America, and the Middle East
Dr. Lumpkin received his B.A. from Davidson College, M.D. from Wake Forest University School of Medicine, and M.Sc. from the University of London as a Fulbright Scholar. He completed a pediatric residency and pediatric infectious disease fellowship at the Mayo Clinic. He holds professional certifications in pediatrics (U.S.) and tropical medicine/hygiene (U.K.)
Dr. Lumpkin joined FDA as director of the Division of Anti-Infective Drug Products in the Center for Drug Evaluation and Research (CDER) and served in this position until 1994. From 1994 to 2000, he served as deputy center director (review management) for CDER.
He has worked in the Office of the Commissioner since late 2000 and has been a deputy commissioner since 2001. Until August 2009, he was also responsible for the oversight of the Office of Pediatric Therapeutics and the Office of Combination Products, both of which he had overseen from the time of their creation by congressional legislation in the early 2000s.
Prior to his work at FDA, Dr. Lumpkin’s professional experience included a three-year appointment as head of pediatric infectious diseases at East Tennessee Children’s Hospital, and a two-year appointment as a medical director at Abbott Laboratories.